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Abstract
Introduction: the hormonal decline that is characteris-
tic of the menopause, in conjunction with the associated 
weight gain, is considered a determinant factor of cardio-
vascular risk.
Objetive: to examine weight status in relation to clinical 
symptoms during the menopausal transition, in women 
referred from primary care to an endocrinology specia-
list, to determine potential cardiovascular risk profiles. 
Method: observational analytic cross-sectional study, 
conducted with data from medical records created at 
time of referral. Study population: 805 women aged 40 
years or older, a sufficient number of subjects and medi-
cal records for cardiovascular risk to be estimated. 
Results: hierarchic cluster analysis distinguished four 
clusters. The prevalence of obesity in each one exceeded 
60%. The highest mean cardiovascular risk was obser-
ved in women who were older and presented obesity and 
hypertension. In younger age groups, the risk was low, 
rising to levels similar to those of the older women by the 
age of 65 years. 
Conclusion: these results suggest that preventive and 
therapeutic monitoring of obesity and modifiable risk 
factors should be conducted during the menopausal tran-
sition, to reduce the risk attributable to these factors, a 
risk that increases with time. 
(Nutr Hosp. 2015;32:1603-1608)
DOI:10.3305/nh.2015.32.4.9380
Key words: Overweight. Obesity. Menopause. Cardiovas-
cular diseases. 
SOBREPESO, OBESIDAD Y RIESGO 
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MENOPÁUSICA
Resumen
Introducción: el declive hormonal característico de la 
menopausia, junto al aumento ponderal añadido, está 
considerado como un factor determinante de riesgo car-
diovascular. 
Propósito: examinar la situación ponderal en relación 
con la sintomatología clínica, durante la transición me-
nopáusica, en mujeres derivadas desde atención prima-
ria a la especialidad de endocrinología, para describir los 
posibles perfiles de riesgo cardiovascular.
Método: se realizó un diseño observacional, analítico, 
de corte transversal, con los datos registrados en las his-
torias clínicas en el momento de la derivación. 805 muje-
res con 40 y más años de edad disponían de los registros 
necesarios para la estimación del riesgo cardiovascular.
Resultados: la agrupación jerárquica distingue cuatro 
grupos. La frecuencia de obesidad en todos ellos superó 
el 60%, observándose los mayores promedios de riesgo 
cardiovascular en las mujeres de mayor edad y elevada 
frecuencia de obesidad e hipertensión arterial. En los 
grupos de menor edad, la estimación del riesgo fue baja, 
incrementándose hasta niveles similares a los de mayor 
edad, al proyectarlo a 65 años. 
Conclusión: estos resultados sugieren la necesidad de 
un seguimiento preventivo y terapéutico de la obesidad y 
los factores de riesgo modificables durante la transición 
menopáusica, para reducir el riesgo atribuible a dichos 
factores con el paso de los años.
(Nutr Hosp. 2015;32:1603-1608)
DOI:10.3305/nh.2015.32.4.9380
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Introduction
Population aging has a particular impact on women, 
whose life expectancy exceeds that of men by almost a 
decade. A distinguishing feature of female aging is the 
menopause, or cessation of ovarian function, which 
gives rise to important physical, psychological and so-
cial changes1,2. The menopause is one of the critical 
stages in a woman’s life, a time of hormonal changes 
that take place throughout the menopausal transition, 
during which the prevalence of obesity is higher and 
mood changes greater than at any other stage of life3,4.
Obesity provokes a unique burden of disease in 
women, in response to diverse biological, hormonal, 
environmental and cultural factors. Reproductive tran-
sitions such as pregnancy and menopause increase 
the risk of obesity5. Today it is considered a chronic 
disease, the prevalence of which (defined as BMI>30 
kg/m2) increases progressively. It is most commonly 
found in the USA, followed by the UK and Central 
Europe. The global incidence exceeds 50% of the po-
pulation, which has led to it being termed the epidemic 
of the twenty-first century6.
According to the latest National Health Survey, 
obesity in Spain has increased by 17% in recent years, 
and overweight by 37%7. The regions of Murcia, An-
dalusia, Extremadura and the Canary Islands have the 
highest prevalence of obesity, and it is more common 
among women than among men in all regions8,9.
Among the determinant factors of obesity are the 
existence of an energy imbalance between intake 
and expenditure, and situations of stress and anxiety, 
which directly affect nutritional behaviour10. These 
factors are notably present in women during the pe-
rimenopause, due to the physiological, emotional and 
psychosocial consequences suffered by many women, 
which thus contribute to weight gains11-13.
Life expectancy at birth for women is 83 years, and 
so one third of a woman’s life will be lived in the post-
menopausal period. One characteristic of this period 
is the presence of hypo-oestrogenism, which, together 
with the increased body weight, is a risk factor for car-
diovascular disease14-17.
The aim of this study is to assess cardiovascular risk 
in relation to weight status, among female subjects 
whose age range includes the menopausal transition 
and who are referred from primary care to endocrino-
logy consultation, within the public health system of 
Granada (southern Spain).
Method 
An observational, analytic, cross-section study was 
performed, based on data obtained from patients’ me-
dical records. The study population was composed of 
3,187 patients who were referred from primary care to 
endocrinology consultation, over a period of four years. 
The sample included all women aged 40 years or more 
for whom the necessary records to estimate cardiovas-
cular risk were available. The final sample contained 
805 women, with the characteristics shown in table I.
Procedure 
Body Mass Index (BMI) is a parameter that is sim-
ple to calculate and extremely useful for classifying 
subjects according to weight status. Moreover, it ena-
bles comparisons to be made between individuals with 
different characteristics and even from different sam-
ple populations. According to the Expert Panel on the 
Identification, Evaluation and Treatment of Overwei-
ght and Obesity in Adults18, BMI is considered normal 
in the range 18.5-25 kg/m2, while >25-29 kg/m2 repre-
sents overweight, and ≥30 kg/m2 represents obesity. In 
addition to sex and age, we also considered clinical 
variables such as blood pressure (according to SEH-
SEC criteria)19, total and HDL cholesterol (according 
to ATP III criteria)20, glycaemia, diabetes (if present, 
and according to the criteria of the Expert Committee 
on Diagnosis and Classification of Diabetes Melli-
tus)21 and tobacco consumption. 
Ten-year cardiovascular risk (CVR) was calculated 
by the Framingham equation adapted to the Spanish 
population, with data from the DORICA study22, and 
applying the procedure described by Ramírez23. Re-
sults are expressed as Low-Moderate risk (CVR<10%) 
and High-Very high risk (CVR>40%). 
Algorithms for CVR prediction are an important 
tool to establish therapeutic criteria aimed at redu-
cing the incidence of cardiovascular disease, which 
is the leading cause of death in developed societies. 
The first references in this respect concern the Framin-
gham equation24. Different models are now being used 
to estimate the absolute risk (usually with respect to 
the next 10 years) of suffering a cardiovascular event, 
according to the conjunction of a number of risk fac-
tors (RF) that accumulate within a given period, such 
as sex, age, blood pressure, lipid profile, smoking and 
diabetes25. This absolute risk (AR) value can then be 
used to calculate other forms, such as comparative risk 
(CR), i.e., the risk at the same age without the modifia-
ble RF, marginal risk (MR), i.e., the difference between 
AR and CR, and projected risk at 65 years of age (PR). 
Although BMI as such is not used in any of the stan-
dard prediction equations, there is evidence of its rela-
tionship with sex, age, lipid profile, blood pressure, etc., 
and so we consider it of interest to determine the rela-
tionship between BMI and CVR in women during the 
menopausal transition [26-29] in order to establish pos-
sible risk profiles based on clinical history and treatment.
Statistical analysis
Statistical analysis was performed with SPSS for Win-
dows 17.0. The comparison of the means was determi-
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ned using the Kruskal-Wallis test, and subsequent analy-
sis of multiple comparisons was carried out using the 
Mann-Whitney test. On the basis of the CVR factors exa-
mined, an initial two-stage cluster analysis of CVR was 
conducted, in two phases, in accordance with the Baye-
sian criterion described by Schwarz, and then the k-means 
method, which was complemented with a confirmatory 
principal components analysis with varimax rotation. In 
all cases, results were considered significant at p<0.05.
Results
The women in the study had a mean age of 52.4 ± 
13.6 years. Given the importance of age in relation 
to the menopause, the sample was stratified into four 
subgroups: <50 years (n=311); 50-59 years (n=210); 
60-69 years (n=195) and 70 or more years (n=89). The 
incidence of obesity exceeded 70% in all groups, rea-
ching 82% in the women aged 60-69 years. The in-
cidence of subjects with overweight was 10-20% and 
was highest in those older than 70 years, while the hi-
ghest incidence (18%) of normal weight was among 
the women aged under 50 years (Table I).
The variables used in estimating CVR presented 
significantly higher values between obese (BMI ≥30) 
and non-obese women, except for glycaemia and total 
cholesterol (Table II). 
Levels of cardiovascular risk, shows differences by 
weight status (Table III). 
The exploratory cluster analysis conducted on the 
CVR factors present in the sample revealed four clus-
Table I 











< 50 56 (18%) 33 (10.6%) 222 (71.4%) 311
50 - 59 18 (8.6%) 26 (12.4%) 166 (79%) 210
60 - 69 8 (4.1%) 27 (13.8%) 160 (82.1%) 195
≥ 70 5 (5.6%) 18 (20.2%) 66 (74.2%) 89
52.4±13.6 87 (10.8%) 10 4(12.9%) 614 (76.3%) 805
Table II 
Comparison between Obese (BMI>30) and Non-Obese subjects
BMI 37.1 ± 5.8
(n=614)
BMI 25.1 ± 3.2
(n=191) p-valor
AGE 53.3 ± 13.0 49.7 ± 10.0 < 0.003
SBP 144.4 ± 21.8 131.1 ± 23.6 < 0.001
DBP 89.1 ± 12.3 81.0 ± 13.1 < 0.001
GLYCAEMIA 169.2 ± 60.4 156.0 ± 76.5  0.175
cTotal 205.4 ± 28.5 199.6 ± 39.9  0.063
cHDL 54.6 ± 7.3 52.4 ± 9.6 < 0.003
SBP: Systolic blood pressure; DBP: Diastolic blood pressure; cTotal: Total cholesterol; cHDL: Cholesterol in high density lipoprotein
Table III 
Levels of cardiovascular risk by weight status
Weight status Absolute Comparative Relative Attributable Projected 
Normal 4.4±5.3 1.6±1.4 2.6 ±1.4 3.1±4.4 9.9±4.1
Overweight 9.1±8.4 2.6±1.3 3.2±2.0 6.7±7.7 12.3±7.7
Obesity 9.2±7.1 2.6±1.3 3.3±1.7 6.6±6.2 12.3±6.0
Total 8.7±7.2 2.5±1.4 3.2±1.7 6.3±6.4 12.0±6.1
p-value < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
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ters; table IV shows the main characteristics of these 
clusters, the number of women in each and the statis-
tical significance of the comparison of the means test 
performed. 
The subsequent factor analysis confirmed the 
4-factor model accounting for 78.9% of the variance 
(Table V). 
Discussion
In our sample, the distribution of women by body 
composition revealed a high proportion of obesity 
(>70%) in all age groups and a small proportion of 
women with normal weight (10.8%), of whom over 
50% were less than 50 years of age, which explains the 
large standard deviation values obtained. 
These data reflect the composition of the sample 
(women referred from primary health care to endo-
crinology) and do not reflect the reported prevalence 
of obesity and overweight in Spain. The sample was 
not one of the general population7-9, but of women of 
a particular age range, with characteristic pathological 
features. Nevertheless, the high prevalence of obesity 
recorded is indicative of the magnitude of the problem 
for many women at this stage of life5, and suggests the-
re is a need for better management of body weight in 
the context of primary and secondary health care26-29.
The analysis of CVR in relation to BMI in the me-
nopausal transition requires the use of clinical para-
meters; however, these are not always available, and 
are often unknown by the women concerned. This is 
an area of interest, because consideration of these data 
could reveal an otherwise imperceptible pathology or 
one that is poorly controlled27-30. Our analysis of the 
variables involved in determining CVR in obese and 
non-obese women shows that age was significantly 
greater in the obese subjects, as were systolic and dias-
tolic levels. These circumstances are compatible with 
a situation in which blood pressure is inadequately 
controlled. Total cholesterol levels were also higher in 
obese women, but did not reach statistical significance 
(Table II). On the other hand, HDL cholesterol did not 
fit the expected pattern, with the lowest levels being 
found among the non-obese women, which suggests a 
good response was obtained to the lipid-lowering treat-
ment that many of these women had been prescribed. 
Mean blood glucose levels exceeded the limit esta-
blished for the diagnosis of diabetes20 in both groups, 
between which there were no significant differences. 
The 10-year absolute risk for the different wei-
ght-status groups was significant in all cases (Ta-
ble III). In the women with normal weight, mostly 
aged under 50 years and in the premenopausal stage, 
the probability of suffering a cardiovascular event wi-
thin 10 years is low (<5%) and corresponds to the at-
tributable risk (3.1%). The estimated projected risk at 
65 years is double the AR if the factors remain unchan-
ged, which corroborates the importance of age and the 
protective role of oestrogen in this group16.
The risk attributable to modifiable factors is an im-
portant indicator of the need for intervention and con-
trol of these factors, in order to prevent their cumula-
tive effects over time27-28. The menopausal transition 
progressively increases the risk of stroke in women, 
exceeding that faced by men7-15,31. The AR values ob-
tained highlight the importance of controlling these 
factors for primary prevention26,28,32, as reflected in 
Table IV 
Differential characteristics of the four clusters 
Age BMI SBP DBP Glucose cTotal cHDL CVR-AR CVR-65
1 (n=159) 45.7±6.2 28.5±7.2 122.7±15.1 77.4±10.7 146.1±54.5 170.9±11.9 47.9±4.4 4.9±5.5 9.3±3.5
2 (n=284) 49.1±10.1 35.5±6.0 129.4±11.7 82.7±9.3 183.4±82.5 204.5±8.7 55.5±5.6 6.5±5.6 10.0±4.0
3 (n=118) 56.5±11.9 32.1±6.1 144.9±21.1 88.1±12.2 161.0±69.7 264.4±26.3 59.0±13.6 11.2±9.8 14.4±10.1
4 (n=244) 58.7±10.6 37.6±6.9 165.4±15.5 98.2±10.1 167.5±54.3 195.7±15.5 54.0±5.6 12.4±6.3 15.0±5.3
p-vlaue < 0.001 < 0.001 < 0.001 < 0.001 > 0.05 < 0.001 < 0.001 < 0.001 < 0.001
BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; cTotal: Total cholesterol; cHDL: Cholesterol in high 
density lipoprotein; CVR-AR: Cardiovascular risk-Absolute risk; CVR-65: Cardiovascular risk at age 65 years.
Table V 
Factorial analysis  
(Variance explained by the model: 78.9%)
Factor
1 2 3 4
Age 0.022 0.102 0.869 0.127
BMI 0.839 0.075 -0.214 0.009
SBP 0.690 0.019 0.595 0.070
DBP 0.746 0.041 0.437 -0.013
Glucose 0.019 -0.003 0.126 0.976
Total cholesterol 0.050 0.826 0.063 0.155
cHDL 0.045 0.831 0.052 -0.156
BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic 
blood pressure; cHDL: Cholesterol in high density lipoprotein.
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the PR at 65 years (only calculated at ages below 65 
years), which is significantly higher in situations of 
overweight and obesity, although there were no sig-
nificant differences between these two situations and 
therefore the risk of suffering a cardiovascular event in 
similar in each case.
To derive a clinical profile of these menopausal 
transition women, a hierarchic cluster analysis was 
performed, revealing four clusters from the following 
prognostic outcome variables: age, BMI, systolic and 
diastolic blood pressure, total and HDL cholesterol. 
The analysis of variance, for the four clusters, shows 
the central values for the variables considered, which 
differed significantly among the groups, except glu-
cose, the levels of which revealed poorly-controlled 
hyperglycaemia and were similar in all cases. The fac-
torial analysis confirmed a 4-factor pattern that explai-
ned 78.9% of the variance (Tables IV and V).
The following distinctive features were observed: 
cluster 1 presented the lowest mean age, with 62% of 
the women being aged under 50 years; 38% were of 
normal weight, 72% had normal blood pressure, 100% 
had normal levels of cholesterol and 79% had no dia-
betes. In cluster 2, 48% of the women were aged un-
der 50 years; 91% had obesity, 16% had diabetes, 57% 
had normal blood pressure and 96% had cholesterol 
in the normal-high range; 6.5% presented a moderate 
10-year absolute risk. In cluster 3, 62% of the women 
were aged 50-69 years, 63% were obese, 69% had 
hypertension, 93% had normal-high cholesterol and 
37% had diabetes. Finally, in cluster 4, 81% of the wo-
men were aged over 50 years, 91% had obesity, 100% 
suffered hypertension, 73% had normal-high choleste-
rol and 34% had diabetes.
The highest mean risk values were obtained for 
cluster 3 (11.2%) and cluster 4 (12.4%). The groups 
of older women presented the highest levels of AR and 
PR to 65 years, with values of 14.4 and 15% in clusters 
3 and 4, respectively, if modifiable factors remained 
unchanged until that age, which underlines the impor-
tance of controlling these factors33.
Conclusions
The results obtained support an explanatory model 
with four profiles: 1) Obesity-Hypertension; 2) Dys-
lipidaemia; 3) Age-Hypertension; 4) Diabetes. Each 
profile has a different effect on CVR, and so our study 
sample can be classified into four risk groups, each 
with a specific necessity as to the type of imminent 
control required for the primary prevention of cardio-
vascular disease. Groups 3 and 4 contain the women 
at highest risk, with a profile of greater age and a high 
prevalence of obesity, hypertension, hypercholestero-
laemia and diabetes. At the other extreme are Groups 
1 and 2, with a lower average age and at less risk. In 
all groups, the excess risk attributable to the factors 
considered was higher among those aged 60-69 years, 
which emphasises the need for special preventive and 
therapeutic monitoring of this age group.
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